Huntsworth, a provider of healthcare communications programs, completed the acquisition of a 70% stake in CC, strategic market access, health economics and outcomes research consultancy, and a 85% stake in Kyne, a health communications agency, for a combined consideration of €31m. "We are delighted to welcome CC and KYNE into the Huntsworth Group as both businesses substantially expand our healthcare offering. CC brings health economics and market access to enhance the scientific evidence capability of MEDiSTRAVA, our Medical division. KYNE brings an expanded capability in healthcare public relations and patient advocacy to the Evoke Group to support additional briefs from global clients. These acquisitions demonstrate Huntsworth's commitment to supporting the changing needs of pharmaceutical and biotech clients," Paul Taaffe, Huntsworth CEO.